Pol F. Boudes
2022 - Galectin Therapeutics
In 2022, Pol F. Boudes earned a total compensation of $794.6K as M.D., Chief Medical Officer at Galectin Therapeutics, a 14% decrease compared to previous year.
Compensation breakdown
| Bonus | $142,500 |
|---|---|
| Option Awards | $73,940 |
| Salary | $473,333 |
| Other | $104,804 |
| Total | $794,577 |
Boudes received $473.3K in salary, accounting for 60% of the total pay in 2022.
Boudes also received $142.5K in bonus, $73.9K in option awards and $104.8K in other compensation.
Rankings
In 2022, Pol F. Boudes' compensation ranked 3,514th out of 5,744 executives tracked by ExecPay. In other words, Boudes earned more than 38.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,514 out of 5,744 | 39th |
Division Manufacturing | 1,999 out of 3,128 | 36th |
Major group Chemicals And Allied Products | 954 out of 1,416 | 33rd |
Industry group Drugs | 892 out of 1,317 | 32nd |
Industry Pharmaceutical Preparations | 650 out of 963 | 33rd |
Source: SEC filing on October 6, 2023.
Boudes' colleagues
We found two more compensation records of executives who worked with Pol F. Boudes at Galectin Therapeutics in 2022.